Increased Aggressiveness of Thyroid Cancer in Patients with Graves' Disease*
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
To evaluate whether coexistence of Graves' disease affects the prognosis of thyroid cancer we examined the clinical and pathological characteristics of 22 differentiated thyroid carcinomas concomitant with hyperthyroidism; 13 were associated with Graves' disease, and 9 with autonomous thyroid nodules. Carcinomas were identified in a consecutive series of 359 hyperthyroid patients (132 with Graves' disease and 227 with autonomous thyroid nodules) who underwent surgery during a 6-yr period. One hundred and thirty-seven thyroid carcinomas were found in the 582 euthyroid patients operated on in the same period. In Graves' patients, carcinomas were more often multifocal (46.1% vs. 0%), locally invasive (61.5% vs. 11.1%), and metastatic to lymph nodes (61.5% vs. 11.1%) or to distant sites (23.0% vs. 0%) than in patients with autonomous thyroid nodules. In addition, carcinomas concomitant with Graves' disease were larger (3.3 +/- 1.8 vs. 1.0 +/- 0.7 cm) than the ones associated with autonomous thyroid nodules and showed a high recurrence rate. In euthyroid patients, aggressiveness of thyroid cancer was intermediate. Serum TSH levels were suppressed in all hyperthyroid patients with thyroid cancer. However, circulating thyroid-stimulating antibodies were present in 12 of 13 cancer patients with Graves' disease, but were absent in patients with autonomous thyroid nodules. Our study suggests, therefore, that TSAb may play a role in determining the high aggressiveness of thyroid cancer in Graves' disease patients and indicates that a vigorous treatment should be pursued in this subgroup of patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ABERRANT EXPRESSION OF HLA-DR ANTIGEN ON THYROCYTES IN GRAVES' DISEASE: RELEVANCE FOR AUTOIMMUNITY
Hanafusa, T., Chiovato, L., Doniach, D., Pujol-Borrell, R., Russell, R. C. G., & Bottazzo, G. F. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90628-1 · Cited by 706
(1964) · Annals of Internal Medicine · doi:10.7326/0003-4819-60-4-742_2 · Cited by 688
Papillary thyroid carcinoma: A 10 year foliow-up report of the impact of therapy in 576 patients
Mazzaferri, E. L., & Young, R. L. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90573-8 · Cited by 670
Autoantibodies to the Thyrotropin Receptor
SMITH, B. R., McLACHLAN, S. M., & FURMANIAK, J. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-1-106 · Cited by 575
Autoimmune Thyroid Disease: Developments in Our Understanding
WEETMAN, A. P., & MCGREGOR, A. M. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-2-309 · Cited by 340
Immune Mechanisms In Graves' Disease
BURMAN, K. D., & BAKER, J. R. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-2-183 · Cited by 216
Thyroid carcinoma and radiation. A Chicago endemic
DeGroot, L. J. (1973) · JAMA · doi:10.1001/jama.225.5.487 · Cited by 193
Incidence of thyroid carcinoma in Graves' disease
Shapiro, S. J., Friedman, N. B., PERZIK, S. L., & Catz, B. (1970) · Cancer · doi:10.1002/1097-0142(197012)26:6<1261::aid-cncr2820260613>3.0.co;2-p · Cited by 141
Thyroid carcinoma in thyrotoxic patients treated by surgery
Pacini, F., Elisei, R., Coscio, G. C. D., Anelli, S., Macchia, E., Concetti, R., Miccoli, P., Arganini, M., & Pinchera, A. (1988) · Journal of Endocrinological Investigation · doi:10.1007/bf03350115 · Cited by 130
Thyroid carcinoma in Graves' disease.
Farbota, L. M., Calandra, D. B., Lawrence, A. M., & Paloyan, E. (1985) · PubMed · Cited by 127
Cited by
Management of a Solitary Thyroid Nodule
Desforges, J. F., & Mazzaferri, E. L. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302253280807 · Cited by 1,412
New developments in the diagnosis and treatment of thyroid cancer
Schneider, D. F., & Chen, H. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21195 · Cited by 316
TUTTLE, R. M., LEMAR, H., & BURCH, H. B. (1998) · Thyroid · doi:10.1089/thy.1998.8.377 · Cited by 286
Surgical management of Graves disease in childhood and adolescence: an institutional experience
Sherman, J., Thompson, G. B., Lteif, A., Schwenk, W. F., van Heerden, J., Farley, D. R., Kumar, S., Zimmerman, D., Churchward, M., & Grant, C. S. (2006) · Surgery · doi:10.1016/j.surg.2006.07.040 · Cited by 66
Metadata
- Authors
- BELFIORE, A., GAROFALO, M. R., GIUFFRIDA, D., RUNELLO, F., FILETTI, S., FIUMARA, A., IPPOLITO, O., & VIGNERI, R.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1990-04
- Volume
- 70
- Issue
- 4
- Pages
- 830-835
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2121153655
- Cited by
- 295
- References
- 20
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.